Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24170388 | 0.87 | CYP3A4 (0.49) | CYP3A4TSHRATMTDP1PRSS1 | |
| SCHEMBL9478682 | 0.87 | CYP3A4 (0.49) | CYP3A4TSHRATMTDP1PRSS1 | |
| SCHEMBL12631799 | 0.78 | CYP3A4 (0.53) | CYP3A4TSHRATMTDP1PRSS1 | |
| SCHEMBL26386523 | 0.78 | CES2 (0.46) | TSHRFAAHZDHHC7LCKPPARD | |
| SCHEMBL26386520 | 0.78 | CES2 (0.46) | TSHRFAAHZDHHC7LCKPPARD | |
| SCHEMBL7174572 | 0.78 | CES2 (0.46) | TSHRFAAHZDHHC7LCKPPARD | |
| SCHEMBL27969438 | 0.78 | CES2 (0.46) | TSHRFAAHZDHHC7LCKPPARD | |
| SCHEMBL26386518 | 0.78 | PLA2G2C (0.46) | TSHRCA2FAAH | |
| SCHEMBL26386524 | 0.78 | PLA2G2C (0.46) | TSHRCA2FAAH | |
| SCHEMBL27574699 | 0.76 | CYP3A4 (0.55) | CYP3A4TSHRATMTDP1PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312449-A1 | CARBOXYLIC ACID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | BOTREE CYCLING SCI & TECH CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| EP-4177241-A1 | CARBOXYLIC ACID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Botree Cycling Sci & Tech Co., Ltd. (CN) | 2023-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312449-A1 | CARBOXYLIC ACID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SLC7A11, SLC7A1, SLC39A11 | CYP3A4 737/4885TSHR 4281/4885ATM 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.